Cannabis Stock Gainers And Losers From January 25, 2021

Monday, 25 January 2021, 22:41:25
GAINERS: Primo Nutraceuticals (PINK: BUGVF ) shares closed up 80% at $0.90 MGC Pharmaceuticals (PINK: MGCLF ) shares closed up 55% at $0.03 High Tide (OTCQB: HITIF ) shares closed up 21.77% at $0.47 BioHarvest Sciences (OTC: CNVCF) shares closed up 17.33% at $0.47 Helix Technologies (OTCQB: HLIX ) shares closed up 10.94% at $0.71 Cannabix Technologies (PINK: BLOZF ) shares closed up 8.39% at $1.28 CURE Pharmaceutical Hldg (OTCQB: CURR ) shares closed up 6.06% at $1.40 Cara Therapeutics (NASDAQ: CARA ) shares closed up 2.61% at $19.65 LOSERS: iAnthus Capital Hldgs (PINK: ITHUF ) shares closed down 30.98% at $0.29 Full story available on Benzinga.com
— Benzinga

Cara Therapeutics, Inc. (NASDAQ:CARA) CEO Derek T. Chalmers Sells 6,078 Shares

Saturday, 2 January 2021, 11:32:41
Cara Therapeutics, Inc. (NASDAQ:CARA) CEO Derek T. Chalmers sold 6,078 shares of the business’s stock in a transaction that occurred on Wednesday, December 30th. The stock was sold at an average price of $15.30, for a total value of $92,993.40. Following the sale, the chief executive officer now owns 936,593 shares of the company’s stock, […]
— Watchlist News

Stamford-based Cara Therapeutics seeks FDA approval for drug for kidney-disease patients

Monday, 28 December 2020, 20:00:00
If the FDA approves Cara Therapeutics’ application, its Korsuva injection would be the Stamford-based company’s first treatment to go on the market.
— CT Insider

Derek T. Chalmers Sells 7,500 Shares of Cara Therapeutics, Inc. (NASDAQ:CARA) Stock

Monday, 14 December 2020, 11:40:42
Cara Therapeutics, Inc. (NASDAQ:CARA) CEO Derek T. Chalmers sold 7,500 shares of the business’s stock in a transaction on Thursday, December 10th. The stock was sold at an average price of $15.29, for a total transaction of $114,675.00. Following the transaction, the chief executive officer now owns 933,921 shares in the company, valued at $14,279,652.09. […]
— Watchlist News

Asia Pacific Medical Marijuana Market Assessments Report 2020 | Cannabis Sativa, Cara Therapeutics, CannaGrow Holdings, Growbox Sciences, United Cannabis, GreenGro Technologies, Lxaria Crop

Monday, 23 November 2020, 18:02:23
Medical marijuana is a type of drug that is used to treat a number of medical conditions such as chronic pain, Alzheimer’s, depression, nausea, cancer, and epilepsy. Since marijuana is a highly addictive drug, governments of several countries have enforced
— OpenPR